Comments

ITeos Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does ITeos Therapeutics (ITOS) operate in?

ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ITOSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

ITeos Therapeutics (ITOS) Forecast

News Earnings ITeos Therapeutics (ITOS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

ITeos Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ITOS | Benzinga

Explore ITeos Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ITOS.

Open	$7.91
Close	-
Volume / Avg.	299.71K / 737.39K
Day Range	$7.87 - $8.04
52 Wk Range	4.80 - 18.70
Market Cap	$302.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	8.51%
Days to Cover	3.95

Recent News

This Wayfair Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

Avi Kapoor

Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile

iTeos ends belrestotug program with GSK after Phase 2 trial fails to meet key survival goals; company explores strategic options to boost shareholder value.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.91
Close	-
Volume / Avg.	299.71K / 737.39K
Day Range	$7.87 - $8.04
52 Wk Range	4.80 - 18.70
Market Cap	$302.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	8.51%
Days to Cover	3.95

About ITeos Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with opti...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ITeos Therapeutics (ITOS) stock?

You can purchase shares of ITeos Therapeutics (NASDAQ:ITOS) through any online brokerage.

View our list of the best stock brokerages

Who are ITeos Therapeutics (ITOS) competitors?

Other companies in ITeos Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA), Neurogene (NASDAQ:NGNE) and Abeona Therapeutics (NASDAQ:ABEO).

What is the forecast, or price target, for ITeos Therapeutics (ITOS) stock?

ITeos Therapeutics has a consensus price target of $17.33.

What is the current price for ITeos Therapeutics (ITOS)?

The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $7.915 last updated May 16, 2025 at 11:38 AM EDT.

Does ITeos Therapeutics (ITOS) pay a dividend?

There are no upcoming dividends for ITeos Therapeutics.

When is ITeos Therapeutics (NASDAQ:ITOS) reporting earnings?

ITeos Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is ITeos Therapeutics (ITOS) going to split?

There is no upcoming split for ITeos Therapeutics.

What sector and industry does ITeos Therapeutics (ITOS) operate in?

ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.